about
Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitorEvaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.Evaluation of different techniques for identification of human papillomavirus types of low prevalenceMultiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalitiesBiological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma.Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus.The HPV transcriptome in HPV16 positive cell lines.Prevalence of human papillomavirus types in cervical and oral cancers in central India.HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?Genotyping of AAV plasmid stocks: quality control in adeno-associated virus vector production.Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series.Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.C-terminal deletions of Merkel cell polyomavirus large T-antigen, a highly specific surrogate marker for virally induced malignancy.Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerBiological activity of probable/possible high-risk human papillomavirus types in cervical cancerHuman Polyomaviruses and Other Human Viruses in Neuroendocrine TumorsDiagnosing Cervical Cancer and High-Grade Precursors by HPV16 Transcription Patterns
P50
Q28286766-43249907-BB6C-40C5-934F-D744C47B0CD2Q35192200-105AB788-DEC3-47D8-9FDD-E3A2E37AC3D9Q35273769-F0C4E6F8-9165-4DB0-AEF8-C2D5A84DF980Q36673134-4140EBAA-70C8-4171-B34E-16AFF7C7AA7CQ36826745-E2EA6465-B1BE-416E-8C4A-5BEC451E9A1FQ37003406-46A69EBE-611B-47C5-9461-02E71A50BF91Q37348338-160424F1-F53D-448A-BFDA-AA8FC9B9B6F3Q38419575-039D355B-093A-4459-B9C9-DFCE0F82F0DEQ39570308-AE7341EA-C32A-4409-95C2-7D3423CA9121Q44457555-F25E99CA-51F3-495D-BF40-DA46E4A732E5Q44675828-C2C1E66E-8B07-4068-B59D-CDB7ACB10DAEQ44749805-A3FFD484-D002-4808-BD07-C72D9B745E37Q45198128-23EC9066-AD95-4E46-8FDC-E1FA2576B0DCQ45338163-F35F14FD-3CA8-4F94-B2EA-FE899DB16054Q51827780-4788AB10-9FC3-46F3-AC11-5A12CA23C5B4Q54274939-121FCE04-201E-4FE7-9738-866582DDFA14Q54289295-BEC193E9-580E-4D88-813A-8652AA5FACBFQ54306363-DB2AC677-C78C-4555-95DC-EC04D70FEF91Q54482654-5037D268-ECFB-4DAE-AAAB-0A76FEE72E40Q57569082-23C586ED-5692-4263-AE80-CC7D38006988Q58279938-9B93D797-9E8E-4F5B-A018-3D6AC801E3DEQ58813706-078CF6B3-65F6-4750-AE1A-76C1110631E1Q58813726-5E31EA7C-8AD8-4DFB-BDFE-09064083A2EB
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Markus Schmitt
@ast
Markus Schmitt
@en
Markus Schmitt
@es
Markus Schmitt
@nl
Markus Schmitt
@sl
type
label
Markus Schmitt
@ast
Markus Schmitt
@en
Markus Schmitt
@es
Markus Schmitt
@nl
Markus Schmitt
@sl
prefLabel
Markus Schmitt
@ast
Markus Schmitt
@en
Markus Schmitt
@es
Markus Schmitt
@nl
Markus Schmitt
@sl
P214
P106
P21
P214
P31
P496
0000-0002-7827-6694
P734
P735
P7859
viaf-95598827